Latest News - Becton Dickinson
Top Corporates Hub
Becton Dickinson
Becton, Dickinson and Company: Now Is A Great Time To Buy
02.07.2026 00:54
Becton, Dickinson and Company boasts a few high-margin, high-growth product lines that should fuel a return to sustainable growth. Read why BDX stock is a Buy.
Becton, Dickinson - Stable Undervaluation In 1Q26, Upside Is There
01.07.2026 11:32
BDX looks undervalued at 12â13x P/E with 7â8% growth, a 2.78% dividend, buybacks, and debt reduction. Click for more on BDX stock.
BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System
01.07.2026 08:16
Becton, Dickinson & Company (NYSE:BDX) is one of the best value stocks to buy right now. On June 23, BD (Becton, Dickinson & Company) announced that its CentroVena One Insertion System was awarded an Innovative Technology contract by Vizient, the nation’s largest provider-driven healthcare performance improvement company. This contract recognizes the system as a breakthrough […]
IV Equipment Market by Type, Application, End User - Global Forecast to 2031
30.06.2026 11:32
The global IV equipment market is set to reach USD 23.92 billion by 2031, expanding from USD 17.82 billion in 2026, at a CAGR of 6.1%. Growth is fueled by rising chronic disease prevalence and increasing hospitalizations, along with a shift towards home-based and outpatient care. Technological advancements such as needle-free connectors and smart infusion pumps are elevating market adoption. North America leads the market, driven by a robust healthcare infrastructure and high adoption of medical
Best Dividend Aristocrats: June 2026
27.06.2026 06:28
Dividend Aristocrats beat SPY YTD as June rebounds; CAT tops 2026 gains.
BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System
23.06.2026 10:50
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that its BD® CentroVena One™ Insertion System has been awarded an Innovative Technology contract from Vizient®, the nation's largest provider-driven healthcare performance improvement company. This contract recognizes products with the potential to drive meaningful improvements in healthcare delivery.
Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products
23.06.2026 08:35
Becton, Dickinson and Company (NYSE:BDX) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. On June 6, 2026, Becton, Dickinson and Company (NYSE:BDX) issued a nationwide voluntary recall for specific lots of its ChloraPrep™ Clear 1 mL and FREPP™ Clear 1.5 mL skin preparation applicators due to potential fungal contamination […]
Becton Dickinson's CentroVena One Insertion System Awarded Innovative Technology Contract From Vizient; Terms Not Disclosed
23.06.2026 06:55
The contract was awarded following a review by hospital experts serving on Vizient's client-led councils, and recognizes that CentroVena One™ offers differentiated capabilities through its all-in-one design with the
How to Approach Abbott Stock Following Its Sharp YTD Decline?
22.06.2026 13:10
ABT falls 29.4% YTD as respiratory testing weakness, China uncertainty and acquisition dilution pressure results and outlook.
3 Excellent Dividend Stocks to Buy on the Dip
22.06.2026 06:05
Don't wait too long to get in on these outstanding dividend payers.
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy?
21.06.2026 11:09
On June 17, 2026, CONMED Corporation announced that John E. Gallagher will become Executive Vice President, Chief Financial Officer, and principal financial and accounting officer from July 15, 2026, succeeding Todd Garner, who will remain in an advisory role until November 2, 2026. Gallagher’s nearly three decades of finance leadership across healthcare and industrial companies, including senior roles at Certara, Cue Health, and Becton Dickinson, signals a refreshed approach to CONMED’s...
BofA Trims Becton Dickinson (BDX) Target as Medtech Headwinds Persist
15.06.2026 19:24
Becton, Dickinson and Company (NYSE:BDX) is included among the Top 10 Income Stocks with the Highest Upside Potential. On June 12, BofA lowered its price recommendation on Becton, Dickinson and Company (NYSE:BDX) to $170 from $177. It reiterated a Neutral rating on the shares. The analyst noted that the firm’s services team continues to observe […]
Becton, Dickinson: A More Streamlined Business With Mid-To-High Teens Return Potential
01.06.2026 05:03
Becton Dickinson expects to achieve currency-neutral revenue growth in the low single-digit range for the current fiscal year. Read more here.
Becton, Dickinson: A More Streamlined Business With Mid-To-High Teens Return Potential
01.06.2026 05:03
Becton Dickinson expects to achieve currency-neutral revenue growth in the low single-digit range for the current fiscal year. Read more here.
How Abbott's Diagnostics Unit Is Shaping Up Through the Rest of 2026
27.05.2026 12:46
ABT's Diagnostics unit witnesses mixed Q1 results as Core Lab growth offsets China weakness and softer respiratory testing demand.
BD Launches Elyra Thulium Fiber Laser System for Kidney Stone Care
22.05.2026 14:13
BDX launches the Elyra Thulium Fiber Laser system to streamline kidney stone care and boost workflow flexibility for urology teams.
BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System
21.05.2026 10:50
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the introduction of the Elyra™ Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete BD's kidney stone care portfolio for urology teams. Designed to enhance efficiency, versatility, and procedural workflow across urologic stone management and soft tissue procedures, the innovative new system supports consistent performance in demanding clinical environments.
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
19.05.2026 10:05
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
19.05.2026 10:05
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Gerard (Jerry) Porreca has joined the company as Executive Vice President, Quality and Regulatory.
Peter Menziuso Named EVP and President, BD Interventional
18.05.2026 06:51
FRANKLIN LAKES, N.J., May 18, 2026 /PRNewswire/ -- BD , a leading global medical technology company, today announced that Peter Menziuso has been named executive vice president and president, BD...